Publications Publicity Sample Clauses

Publications Publicity. Authorship of publications emanating from the use of the Materials hereunder must be in keeping with the International Committee of Medical Journal Editors Authorship Guidelines (xxxx://xxx.xxxxx.xxx/icmje-recommendations.pdf) as amended from time to time. Where the Recipient wishes to publish any information concerning the Project (in either oral or written form), the Provider must be notified and provided with a copy of the publication at least ten (10) days prior to submission of the proposed publication. The Provider must inform the Recipient whether any information related to the publication must be removed or included and provide reasons to substantiate the removal or addition of such information. The Provider must be supplied with a final copy of the publication before publication by the Recipient. The Recipient must acknowledge the Provider’s contribution of the Material unless otherwise requested by the Provider. Neither Party shall use the name of the other Party or its employees in any advertisement, press release or other publicity without prior written approval of the other Party. Notwithstanding the above, and where relevant, publications will be subject to the applicable protocol and relevant third-party agreements.
Sample 1Sample 2Sample 3See All (11)
AutoNDA by SimpleDocs
Publications Publicity. No publicity releases (including news releases and advertising) relating to this Agreement and the services hereunder including announcements upon contract execution shall be issued by COMPANY without the prior written approval of CUSTOMER, in its sole discretion.
Sample 1Sample 2
Publications Publicity. 13.1. The Licensors shall ensure that no publications in writing, in scientific journals or orally at scientific conventions relating to the Licensed Technology, the Development Plan, the Development Results or the Product, which are subject to the terms and conditions of this Agreement, are published by it, the Researcher or any other of its other researchers, without first seeking the consent of the Company, in writing. 13.2. The Company undertakes to reply to any such request for publication by the Licensors within sixty (60) days of its receipt of a request in writing in connection with the publication of articles in scientific journals, and within fifteen (15) days of its receipt of a request in connection with article abstracts. The Company may only decline such an application upon reasonable grounds, which shall be fully detailed in writing. 13.3. Should the Company decide to object to publication as provided in sub-section13.2, above, publication shall be postponed for a period of not more than three (3) months from the date the publication was sent to the Company to enable the filing of patent applications, it being understood and agreed, however, that no such publication shall include the Company’s proprietary information. 13.4. In the absence of any specific agreement between the parties which agreement shall not be unreasonably withheld or delayed, neither party shall originate any publicity, news release or public announcement, written or oral, whether to the public or press, relating to the provisions of this Agreement, performance under this Agreement or any of its terms or to any amendment hereto save only such announcement as in the opinion of counsel for the party making such announcement or its Affiliates is required by law or the rules of any stock exchange to be made. 13.5. For the avoidance of doubt, the provisions of this section in connection with the prohibition against publication shall not apply to presentations made by students and researchers within the Licensors’ institutions provided that any persons who are present during such presentations are obligated to maintain the confidentiality thereof pursuant to written agreements signed by them containing terms and conditions materially similar to those set forth in section 12, above.
Sample 1
Publications Publicity. Physician has the right to publish the results of the treatment of patient(s) with the Investigational Product in accordance with the Protocol in peer-reviewed literature. Physician agrees to provide a copy of any proposed abstracts and manuscripts for publication, including slides and texts of oral or other public presentations and texts to Ultragenyx at least thirty (30) days prior to its submission for publication or presentation. q. Publicaciones/Publicidad. EL MÉDICO tiene derecho a publicar los resultados del tratamiento del paciente con el Producto de Investigación de acuerdo con el Protocolo en la literatura revisada por pares. EL MÉDICO se compromete a proporcionar una copia de los resúmenes y manuscritos propuestos para su publicación, incluyendo las diapositivas y los textos de las presentaciones orales u otras presentaciones públicas y los textos a ULTRAGENYX al menos treinta (30) xxxx antes de su presentación para la publicación o presentación. No publication or presentation will contain any of Confidential Information. Physician will remove all Confidential Information from publications or presentations where this is so identified by Ultragenyx. If the proposed publication or presentation contains data or information, which Ultragenyx would like to include in a patent application, Ultragenyx will notify Physician, and he/she will delay such publication or presentation for an additional ninety (90) days for Ultragenyx to file a patent application. i.Ninguna publicación o presentación contendrá Información Confidencial. EL MÉDICO eliminará toda la Información Confidencial de las publicaciones o presentaciones cuando así lo identifique ULTRAGENYX. Si la publicación o presentación propuesta contiene datos o información que ULTRAGENYX desearía incluir en una solicitud de patente, ULTRAGENYX lo notificará al MÉDICO, y éste retrasará dicha publicación o xxxxxxxxxxxx xxxxxxx noventa (90) xxxx adicionales para que ULTRAGENYX presente una solicitud de patente. ii. Physician will comply with recognized ethical standards concerning publications and authorship, including the Uniform Requirements for Manuscripts Submitted to Biomedical Journals, established by the International Committee of Medical Journal Editors. Physician will comply with all applicable requirements regarding disclosure of industry support (financial or otherwise) in connection with such publications and presentations. ii. EL MÉDICO cumplirá con las normas éticas reconocidas en relación...
Sample 1
Publications Publicity. 1. The Parties agree that the dissemination of Project findings by publication or otherwise is a valuable objective of the Project. Joint publications are encouraged with authorship of such publications decided according to ICMJE publication standards. DATA RECIPIENT reserves the sole right to publish the result of any work completed by DATA RECIPIENT under this Agreement, provided however that PanCAN may require DATA RECIPIENT to allow publication by PanCAN in furtherance of its charitable mission so long as PanCAN does not prejudice any intellectual property rights of DATA RECIPIENT. Prior to submission for publication or presentation, DATA RECIPIENT will provide PanCAN thirty (30) days for review of a manuscript. XxxXXX’s comments will be considered in good faith by DATA RECIPIENT. PanCAN and DATA RECIPIENT will arrange expedited reviews for abstracts, poster presentations, or other materials. If requested in writing, any publication may be delayed as necessary to allow for filing of a patent, or as applicable other intellectual property, application. DATA RECIPIENT agrees to cite XxxXXX as the source of the De-Identified Data Set for any results in all presentations, publications, abstracts or other public disclosures of the De-Identified Data Set. 2. DATA RECIPIENT shall provide PanCAN access to, either electronically or in paper form, a copy of every publication of material based on or developed under this Agreement. 3. Neither Party shall use the other Party’s name, trademarks, or other logos in any publicity, advertising, or news release without the prior written approval of an authorized representative of such other Party. 4. The Parties agree that each Party may disclose factual information regarding the existence and purpose of the relationship that is the subject of this Agreement without written permission from the other Party provided that any such statement shall not in any manner imply endorsement by the other Party whose name is being used.
Sample 1
Publications Publicity 
Sample 1Sample 2Sample 3See All (15)

Related to Publications Publicity

  • Publications Neither Party shall publicly present or publish results of studies carried out under this Agreement (each such presentation or publication a “Publication”) without the opportunity for prior review by the other Party, except to the extent otherwise required by Applicable Law, in which case Section 12.3 shall apply with respect to disclosures required by the SEC and/or for regulatory filings. The submitting Party shall provide the other Party the opportunity to review any proposed Publication at least thirty (30) days prior to the earlier of its presentation or intended submission for publication. The submitting Party agrees, upon request by the other Party, not to submit or present any Publication until the other Party has had thirty (30) days to comment on any material in such Publication. The submitting Party shall consider the comments of the other Party in good faith, but will retain the sole authority to submit the manuscript for Publication; provided that the submitting Party agrees to delay such Publication as necessary to enable the Parties to file a Patent if such Publication might adversely affect such Patent. The submitting Party shall provide the other Party a copy of the Publication at the time of the submission or presentation. Notwithstanding the foregoing, BMS shall not have the right to publish or present Ambrx’s Confidential Information without Ambrx’s prior written consent, and Ambrx shall not have the right to publish or present BMS’ Confidential Information without BMS’ prior written consent. Each Party agrees to acknowledge the contributions of the other Party, and the employees of the other Party, in all publications as scientifically appropriate. This Section 12.4 shall not limit and shall be subject to Section 12.5. Nothing contained in this Section 12.4 shall prohibit the inclusion of information in a patent application claiming, and in furtherance of, the manufacture, use, sale or formulation of a Compound, provided that the non-filing Party is given a reasonable opportunity to review, comment upon and/or approve the information to be included prior to submission of such patent application, where and to the extent required by Article 9 hereof. Notwithstanding the foregoing, the Parties recognize that independent investigators have been engaged, and will be engaged in the future, to conduct Clinical Trials of Compounds and Products. The Parties recognize that such investigators operate in an academic environment and may release information regarding such studies in a manner consistent with academic standards; provided that each Party will use reasonable efforts to prevent publication prior to the filing of relevant patent applications and to ensure that no Confidential Information of either Party is disclosed.

  • Publicity The Company, and the Buyer shall have the right to review a reasonable period of time before issuance of any press releases, SEC, OTCBB or FINRA filings, or any other public statements with respect to the transactions contemplated hereby; provided, however, that the Company shall be entitled, without the prior approval of the Buyer, to make any press release or SEC, OTCBB (or other applicable trading market) or FINRA filings with respect to such transactions as is required by applicable law and regulations (although the Buyer shall be consulted by the Company in connection with any such press release prior to its release and shall be provided with a copy thereof and be given an opportunity to comment thereon).

  • MPS LOGO/PUBLICITY No Contractor shall use the MPS Logo in its literature or issue a press release about the subject of this Contract without prior written notice to and written approval of MPS’s Executive Director of Communications & Outreach.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!